The effect of hydralazine on the development of tolerance to continuous nitroglycerin

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 866-875

  Parker, John D ^a   Parker, Andrea B ^b   Farrell, Bernice ^c   Parker, John O ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b SOCAR RESEARCH SA   (Switzerland)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; HYDRALAZINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HEMATOCRIT; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCINTIANGIOGRAPHY; SUBLINGUAL DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT PLANNING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADMINISTRATION, CUTANEOUS; ADULT; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HEMATOCRIT; HUMANS; HYDRALAZINE; MALE; MIDDLE AGED; NITROGLYCERIN; POSTURE; REFERENCE VALUES; SYSTOLE; VASODILATOR AGENTS;

EID: 0030968520     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BAUER, J. A. AND FUNG, H. L.: Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Circulation 84: 35-9, 1991.
2. COHN, J. N., ARCHIBALS, D. G., ZEISCHE, S., FRANCIOSA, J. A., HARSTON, W. E., TRISTANI, F. E., DUNKMAN, B., JACOBS, W., FRANCIS, G. S., FLOHR, K. H., GOLDMAN, S., COBB, F. R., SHAN, P. M., SAWDERS, R., FLETCHER, R. D. LOEB, H. S., HUGHES, V. C. AND BAKER, B.: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration cooperative study (V-Heft). N. Engl. J. Med. 314: 1547-1552, 1986.
3. COHN, J. N., JOHNSON, G., ZIESCHE, S., COBB, F., FRANCIS, G., TRISTTANI, F., SMITH, R., DUNKMAN, F., LOEB, H., WONG, M., BHAT, G., GOLDMAN, S., FLETCHER, R., DOHERTY, J., HUGHES, V., CARSON, P., CINTRON, G., SHABETAI, R. AND HAAKENSON, C. A.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325: 303-310, 1991.
4. DUPUIS, J., LALONDE, G., LEMIEUX, R. AND ROULEAU, J. L.: Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J. Am. Coll. Cardiol. 16: 923-931, 1990.
5. FITCHETT, D., NETO, J., OAKLEY, C. AND GOODWIN, J.: Hydralazine and the management of left ventricular failure. Am. J. Cardiol, 44: 303-309, 1979.
6. FRANCIOSA, J., PIERPOINT, G. AND COHN, J.: Hemodynamic improvement after oral hydralazine in left ventricular failure. Ann. Intern. Med. 86: 388-393, 1977.
7. GOGIA, H., MEHRA, A., PARIKH, S., RAMAN, M., AJIT-UPPAL, J., JOHNSON, J. V. AND ELKAYAM, U.: Prevention of tolerance to hemodyanmic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J. Am. Coll. Cardiol. 26: 1575-1580, 1995.
8. IGNARRO, L. J., LIPPTON, H., EDWARDS, J. C., BARICOS, W. H., HYMAN, A. L., KADOWITZ, P. J. AND GBUETTER, C. A.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitrous oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Then 218: 739-749, 1981.
9. IMHOF, P., RENWALD, D., MULLER, P., HOWALD, H. AND BURKART, F.: Circulatory counter-regulations induced by continuous administration of nitroglycerin. Meth. and Find. Exp. Clin. Pharmacol. 11: 409-414, 1989.
10. LEIER, C. V., Huss, P., MAGORIEN, R. D. AND UNVERFERTH, D. V.: Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation 67: 817-822, 1983.
11. MÜNZEL, T., KURZ, S., RAJAGOPALAN, S. AND HARRISON, D. G.: Hydralazine prevents nitroglycerin tolerance by inhibiting vascular Superoxide production. Circulation 92: (suppl. I), 1-4, 1995a.
12. MÜNZEL, T., SAYEGH, H., FREEMAN, B. A., TARPEY, M. M. AND HARRISON, D. G.: Evidence for enhanced vascular Superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95: 187-194, 1995b.
13. PACKER, M.: What causes tolerance to nitroglycerine? The 100 year old mystery continues. J. Am. Coll. Cardiol. 16: 932-935, 1990.
14. PACKER, M., LEE, W. H., KESSLER, P. D., GOTTLIEB, S. S., MEDINA, N. AND YUSHAK, M.: Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N. Engl. J. Med. 317: 799-804, 1987.
15. PARKER, J. D., FARRELL, B., FENTON, T., COHANIM, M. AND PARKER, J. O.: Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84: 2336-2345, 1991.
16. PARKER, J. D., FARRELL, B., FENTON, T. AND PARKER, J. O.: Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin. J. Am. Coll. Cardiol. 20: 616-622, 1992.
17. PARKER, J. D. AND PARKER, J. O.: Effect of therapy with an angiotensin- converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. J. Am. Coll. Cardiol. 21: 1445-1453, 1993.
18. PARKER, J. O. AND FUNG, H.-L.: Transdermal nitroglycerin in angina pectoris. Am. J. Cardiol. 54: 471-476, 1984.
19. PARKER, J. O., FUNG, H.-L., RUGGIRELLO, D. AND STONE, J. A.: Tolerance to isosorbide dinitrate: Rate of development and reversal. Circulation 68: 1074-1080, 1983.
20. PARKER, J. O., VANKOUGHNETT, K. A. AND FUNG, H.-L.: Transdermal isosorbide dinitrate in angina pectoris: Effects of acute and sustained therapy. Am. J. Cardiol. 54: 8-13, 1984.
21. REICHER, N., PRIEST, C., ZIMRIN, D. AND SUTTON, M. S.: Antianginal effects of nitroglycerin patches. Am. J. Cardiol. 54: 1-7, 1984.
22. THADANI, U., FUNG, H.-L., DARK, A. C. AND PARKER, J. O.: Oral isosorbide dinitrate in angina pectoris. Comparison of duration of action and dose response relation during acute and sustained therapy. Am. J. Card. 89: 1074-1080, 1982.
23. THADANI, U., HAMILTON, S. F., OLSEN, E., ANDERSON, J., VOYLES, W., PRASAD, R. AND TEAGUE, S. M.: Transdermal nitroglycerin patches in angina pectoris: Dose titration, duration of effect and rapid tolerance. Ann. Int. Med. 105: 485-492, 1986.
24. UNGER, P., BERKENBOOM, G. AND FONTAINE, J.: Interaction between hydralazine and nitrovasodilators in vascular smooth muscle. J. Cardiovasc. Pharmacol. 21: 478-183, 1993.
25. ZIMRIN, D., REICHEK, N., BOGIN, K., AURIGEMMA, G., DOUGLAS, P., BERKO, B. AND FUNG, H.-L.: Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 77: 1376-1384, 1988.